Bridget Flynn: An Opportunity to Support Medication Management for Stroke Survivors
Bridget Flynn, Director of Development, Principal and Major Gifts at Woods Hole Oceanographic Institution, shared Jonathan Rosand‘s post on LinkedIn:
”Sharing this opportunity that could make a meaningful difference for stroke survivors.
If you or someone you know has had a stroke in the past year, this fully remote study from Mass General Brigham and Harvard Medical School is focused on helping with medication management.
Details below.”
Jonathan Rosand, Founder of Global Brain Care, Director of Brain Care Labs at Mass General Brigham, shared on LinkedIn:
”Have you or a loved one had a stroke in the past year, and would you like help managing your medications?
The Savvy Study Team at Mass General Brigham and Harvard Medical School are now recruiting stroke survivors across the U.S. for a fully remote study to support you in taking your medications.
Please see the flyer below for more details.
Visit for more information and to express interest.
Get in touch at [email protected] if you have any questions.”
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia